查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1560959

2024-2032 年按產品、技術、應用（腫瘤學、中樞神經系統、免疫學、呼吸醫學、感染等）、最終用戶和地區分類的精準醫學市場報告

Precision Medicine Market Report by Product, Technology, Application (Oncology, Central Nervous System, Immunology, Respiratory Medicine, Infections, and Others), End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

2023年全球精準醫療IMARC Group規模達752億美元。基因組學的重大進步、醫療保健個人化的提高、慢性病盛行率的上升、技術創新、研究投資的增加以及向更有效、客製化治療的轉變正在影響精準醫療產業。

精準醫療市場分析：

  • 市場成長與規模：在對個人化治療方式的需求不斷成長和基因組科學進步的推動下，精準醫療市場佔有率正在快速成長。精準醫療市場趨勢反映在精準醫療應用範圍的擴大和流入該領域的大量投資。
  • 主要市場促進因素：主要促進因素包括基因組學技術進步、慢性病盛行率上升、向個人化醫療保健的轉變以及對研發 (R&D) 的大量投資。這些因素共同推動市場向前發展，與人們日益重視更有效和客製化的醫療保健解決方案一致。
  • 技術進步：基因定序、巨量資料分析和生物資訊學的創新至關重要，可以對遺傳資料進行詳細分析，從而促進個人化治療策略。這種技術進步對於標靶治療和精準診斷工具的開發至關重要。
  • 產業應用：精準醫學在腫瘤學、中樞神經系統(CNS) 疾病、免疫學和呼吸醫學等領域有著廣泛的應用，它可以實現量身定做的治療策略，從而改善患者的治療效果和更有效的疾病管理。
  • 主要市場趨勢：一些關鍵的精準醫療市場趨勢包括人工智慧 (AI) 和機器學習 (ML) 的整合，以增強遺傳資料的預測能力並改善患者護理的個人化。市場上伴隨診斷也有所增加，強調了根據個人遺傳資訊調整治療決策的重要性。
  • 地理趨勢：在先進的醫療保健基礎設施和大量醫療保健投資的支持下，北美引領市場。然而，由於醫療保健意識的提高、醫療保健基礎設施的投資以及政府對個人化醫療的支持，亞太地區正在快速成長。
  • 競爭格局：市場競爭激烈，主要參與者專注於創新、策略合作夥伴關係，並擴大其產品組合以包括複雜的精準醫療解決方案。競爭優勢很大程度取決於技術創新、法規核准和市場擴張策略。
  • 挑戰與機會：挑戰包括高成本、複雜的監管環境以及廣泛的資料整合需求。另一方面，這些挑戰為降低成本、最佳化監管策略和開發先進資料分析以提高精準醫療的有效性和可及性提供了創新機會。

精準醫療市場趨勢：

基因組學和生物資訊學的技術進步：

推動精準醫療市場成長的最重要促進因素之一是基因組學和生物資訊學的快速發展。高通量定序技術使基因組定序變得更快、更便宜，使基因組資訊在臨床實踐中廣泛使用。這導致了基於個體基因組成的個人化治療的發展。此外，生物資訊學將生物資料與統計分析和計算工具相結合，在解釋基因組測序產生的大量資料方面發揮著至關重要的作用。這些技術進步為識別導致各種疾病的基因突變以及開發改善治療結果的標靶療法鋪平了道路，從而提高了精準醫療的市場佔有率。

慢性病盛行率增加：

癌症、糖尿病和心血管疾病（CVD）等慢性疾病的全球增加是有助於市場擴張的關鍵精準醫療市場趨勢之一。這些疾病是全世界死亡和殘疾的主要原因，給醫療保健系統帶來了沉重負擔。精準醫學為管理這些疾病提供了一種有前途的方法，根據每位患者獨特的基因譜，設計出針對性的治療方法來治療他們的疾病。這種個人化方法不僅提高了治療效果，還降低了藥物不良反應的風險，從而提高了患者的治療效果並降低了醫療成本。隨著這些疾病的盛行率持續上升，對精準醫療方法的需求預計將成長，從而推動精準醫療市場的成長。

不斷增加的研發投入：

精準醫療產業的研發（R＆D）投資是另一個重要的成長誘導因素。政府、私人實體和慈善組織擴大資助精準醫學的研發活動，以發現新的治療標靶並開發新的診斷工具和治療方法。這項投資對於生物標記的不斷發現、伴隨診斷的發展以及個人化治療的進步至關重要。此類財政支援正在推動創新，並加速將科學發現轉化為臨床應用，從而促進精準醫療佔有率的成長。

轉向個人化醫療保健：

由於對客製化治療方案的需求不斷成長以及對預防醫學的日益重視，人們日益向個人化醫療保健轉變，這正在推動精準醫療市場的成長。患者和醫療保健提供者越來越意識到個人化醫療的好處，例如提高治療效果、最大限度地減少藥物選擇的試驗和錯誤，以及從長遠來看降低治療成本。這一轉變得到了電子健康記錄 (EHR) 與基因組資料整合的支持，這增強了根據個人特徵量身定做醫療的能力。因此，對精準醫療解決方案的需求不斷成長，預計將提高精準醫療市場佔有率。

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球精準醫療市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依產品

  • 耗材
    • 市場趨勢
    • 市場預測
  • 儀器儀表
    • 市場趨勢
    • 市場預測
  • 服務
    • 市場趨勢
    • 市場預測

第 7 章：市場區隔：依技術

  • 巨量資料分析
    • 市場趨勢
    • 市場預測
  • 生物資訊學
    • 市場趨勢
    • 市場預測
  • 基因定序
    • 市場趨勢
    • 市場預測
  • 藥物發現
    • 市場趨勢
    • 市場預測
  • 伴隨診斷
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：按應用

  • 腫瘤學
    • 市場趨勢
    • 市場預測
  • 中樞神經系統 (CNS)
    • 市場趨勢
    • 市場預測
  • 免疫學
    • 市場趨勢
    • 市場預測
  • 呼吸內科
    • 市場趨勢
    • 市場預測
  • 感染
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 9 章：市場區隔：按最終用戶

  • 醫院和診所
    • 市場趨勢
    • 市場預測
  • 診斷中心
    • 市場趨勢
    • 市場預測
  • 製藥和生物技術公司
    • 市場趨勢
    • 市場預測
  • 醫療保健 IT 公司
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 10 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第15章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • AstraZeneca plc
    • Bayer AG
    • bioMerieux SA
    • Bristol-Myers Squibb Company
    • Eli Lilly and Company
    • F. Hoffmann-La Roche AG
    • Illumina Inc.
    • Laboratory Corporation of America Holdings
    • Merck KGaA
    • Novartis AG
    • Pfizer Inc.
    • Qiagen NV
    • Quest Diagnostics Incorporated
    • Thermo Fisher Scientific Inc.
Product Code: SR112024A4567

The global precision medicine market size reached US$ 75.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 168.3 Billion by 2032, exhibiting a growth rate (CAGR) of 9.1% during 2024-2032. Significant advancements in genomics, increasing healthcare personalization, rising prevalence of chronic diseases, technological innovations, growing investment in research, and a shift towards more effective, tailored treatments are influencing the precision medicine industry.

Precision Medicine Market Analysis:

  • Market Growth and Size: The precision medicine market share is experiencing rapid growth, driven by increasing demand for personalized treatment modalities and advancements in genomic science. Precision medicine market trends are reflected in the expanding range of precision medicine applications and the significant investments flowing into the sector.
  • Major Market Drivers: Key drivers include technological advancements in genomics, the rising prevalence of chronic diseases, a shift towards personalized healthcare, and substantial investments in research and development (R&D). These factors are collectively propelling the market forward, aligning with the growing emphasis on more effective and tailored healthcare solutions.
  • Technological Advancements: Innovations in gene sequencing, big data analytics, and bioinformatics are pivotal, enabling the detailed analysis of genetic data, which in turn facilitates personalized treatment strategies. Such technological progress is vital for the development of targeted therapies and precision diagnostic tools.
  • Industry Applications: Precision medicine finds extensive applications across oncology, central nervous system (CNS) disorders, immunology, and respiratory medicine, among others, where it enables tailored therapeutic strategies, leading to improved patient outcomes and more efficient disease management.
  • Key Market Trends: Some of the key precision medicine market trends include the integration of artificial intelligence (AI) and machine learning (ML) to enhance the predictive power of genetic data and improve the personalization of patient care. The market is also seeing a rise in companion diagnostics, emphasizing the importance of aligning therapeutic decisions with individual genetic information.
  • Geographical Trends: North America leads the market, supported by advanced healthcare infrastructure and significant healthcare investments. However, Asia Pacific is rapidly growing due to increasing healthcare awareness, investment in healthcare infrastructure, and governmental support for personalized medicine.
  • Competitive Landscape: The market is highly competitive, with key players focusing on innovation, strategic partnerships, and expanding their product portfolios to include sophisticated precision medicine solutions. The competitive edge is largely defined by technological innovation, regulatory approvals, and market expansion strategies.
  • Challenges and Opportunities: Challenges include high costs, complex regulatory environments, and the need for extensive data integration. On the other hand, these challenges present opportunities for innovation in cost reduction, regulatory strategy optimization, and the development of advanced data analytics to enhance the efficacy and accessibility of precision medicine.

Precision Medicine Market Trends:

Technological advancements in genomics and bioinformatics:

One of the most significant drivers driving the precision medicine market growth is the rapid advancement in genomics and bioinformatics. High-throughput sequencing technologies have made genome sequencing faster and more affordable, enabling the widespread use of genomic information in clinical practice. This has led to the development of personalized treatments based on the genetic makeup of individuals. Moreover, bioinformatics, which combines biological data with statistical analysis and computational tools, plays a crucial role in interpreting the vast amounts of data generated by genomic sequencing. These technological advancements have paved the way for the identification of genetic mutations responsible for various diseases and the development of targeted therapies that improve treatment outcomes, boosting precision medicine market share.

Increasing prevalence of chronic diseases:

The global increase in chronic diseases such as cancer, diabetes, and cardiovascular diseases (CVDs) is one of the crucial precision medicine market trends aiding in market expansion. These conditions are leading causes of death and disability worldwide, placing a significant burden on healthcare systems. Precision medicine offers a promising approach to managing these diseases, with targeted therapies designed to treat each patient's disease based on their unique genetic profile. This personalized approach not only improves the effectiveness of treatment but also reduces the risk of adverse drug reactions, thereby enhancing patient outcomes and reducing healthcare costs. As the prevalence of these diseases continues to rise, the demand for precision medicine approaches is expected to grow, driving the precision medicine market growth.

Growing investment in research and development:

Investment in research and development (R&D) in the precision medicine industry is acting as another significant growth-inducing factor. Governments, private entities, and philanthropic organizations are increasingly funding R&D activities in precision medicine to uncover novel therapeutic targets and develop new diagnostic tools and treatments. This investment is crucial for the continuous discovery of biomarkers, the development of companion diagnostics, and the advancement of personalized therapies. Such financial support is fueling innovations in the pipeline and accelerating the translation of scientific discoveries into clinical applications, thereby fostering the growth of the precision medicine share.

Shift Towards Personalized Healthcare:

The growing shift towards personalized healthcare, driven by the increasing demand for tailored treatment options and the rising emphasis on preventive medicine is bolstering the precision medicine market growth. Patients and healthcare providers are becoming more aware of the benefits of personalized medicine, such as improved treatment efficacy, minimized trial and error in drug selection, and reduced treatment costs in the long run. This shift is supported by the integration of electronic health records (EHRs) with genomic data, which enhances the ability to tailor medical treatment to individual characteristics. As a result, there is a growing demand for precision medicine solutions, which is expected to boost precision medicine market share.

Precision Medicine Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product, technology, application, and end user.

Breakup by Product:

  • Consumables
  • Instruments
  • Services

The report has provided a detailed breakup and analysis of the market based on the product. This includes consumables, instruments, and services.

The growing demand for precision medicine consumables, driven by the recurring need for new reagents and assays in personalized treatment protocols to ensure ongoing precision in patient-specific diagnostic and therapeutic processes is influencing the precision medicine industry.

Besides this, the surge in demand for precision medicine instruments owing to their critical role in advanced diagnostics and therapeutic monitoring, facilitating high-precision, real-time data for personalized healthcare decisions is aiding in market expansion.

Concurrently, the increasing reliance on precision medicine services is fueled by the necessity for expert analysis, interpretation of complex genomic data, and the customization of therapy plans, enhancing the efficacy of personalized treatment strategies.

Breakup by Technology:

  • Big Data Analytics
  • Bioinformatics
  • Gene Sequencing
  • Drug Discovery
  • Companion Diagnostics
  • Others

Drug discovery holds the largest share in the market

A detailed breakup and analysis of the market based on the technology has also been provided in the report. This includes big data analytics, bioinformatics, gene sequencing, drug discovery, companion diagnostics, and others. According to the report, drug discovery accounted for the largest market share.

The demand for precision medicine in drug discovery is mainly propelled by the necessity to develop more effective, safer medications tailored to individual genetic profiles. This approach leverages high-throughput genomic technologies and bioinformatics, enabling researchers to identify novel therapeutic targets and predict drug responses more accurately. It also facilitates the creation of targeted therapies that significantly improve patient outcomes, reduce adverse effects, and expedite the journey from laboratory research to clinical practice, thus creating a favorable outlook for market expansion.

In line with this, the integration of big data analytics in the healthcare sector for deciphering complex datasets, enabling predictive modeling and personalized treatment strategies is positively impacting the precision medicine industry.

Moreover, the rising demand for bioinformatics, essential in precision medicine for analyzing biological data, especially in understanding genetic variations, which facilitates personalized therapeutic strategies and enhances diagnostic accuracy is impelling the market growth.

In confluence with this, gene sequencing technology is fundamental in identifying genetic disorders and tailoring individualized treatments, which is contributing to its expanding demand in the development of precision medicine.

Additionally, the growing use of companion diagnostics for the effective implementation of precision medicine is aiding in market expansion, as they enable the identification of patients likely to benefit from specific treatments, ensuring targeted therapeutic approaches.

Apart from this, emerging technologies like clustered regularly interspaced short palindromic repeats (CRISPR) gene editing and AI-driven predictive models are propelling precision medicine by enabling groundbreaking personalized treatments and advancing our understanding of complex diseases.

Breakup by Application:

  • Oncology
  • Central Nervous System (CNS)
  • Immunology
  • Respiratory Medicine
  • Infections
  • Others

Oncology holds the largest share in the market

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes oncology, central nervous system (CNS), immunology, respiratory medicine, infections, and others. According to the report, oncology accounted for the largest market share.

The demand for precision medicine in oncology is driven by its potential to revolutionize cancer treatment through personalized therapy. By understanding the genetic mutations and molecular characteristics of individual tumors, precision oncology allows for the development of targeted therapies that are more effective and have fewer side effects than traditional treatments. This tailored approach improves patient outcomes, enhances survival rates, and offers hope for those with previously untreatable cancers.

In addition to this, precision medicine also finds extensive applications in CNS disorders due to its potential to tailor treatments for neurological conditions, enhancing efficacy and reducing side effects tailored to individual genetic profiles.

Furthermore, immunology's growing reliance on precision medicine due to its ability to customize immune therapies, thereby improving treatment outcomes for autoimmune diseases by targeting patient-specific immunological pathways is fueling the market growth.

In confluence with this, the push for precision medicine in respiratory medicine for its capacity to personalize therapies for chronic respiratory diseases, optimizing treatment effectiveness and patient management based on individual genetic variations is fostering market expansion.

Moreover, the increasing demand in infections, driven by the precision medicine approach to develop targeted antimicrobial treatments to effectively combat antibiotic-resistant strains and tailored therapy based on the pathogen's genetic makeup is influencing market growth.

Besides this, precision medicine is also gaining traction for its ability to provide customized solutions across various medical fields, enhancing treatment precision, improving clinical outcomes, and offering novel therapeutic options tailored to individual patient profiles.

Breakup by End User:

  • Hospitals and Clinics
  • Diagnostic Centers
  • Pharma and Biotech Companies
  • Healthcare IT Firms
  • Others

Hospitals and clinics hold the largest share in the market

A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospitals and clinics, diagnostic centers, pharma and biotech companies, healthcare IT firms, and others. According to the report, hospitals and clinics accounted for the largest market share.

The demand for precision medicine in hospitals and clinics is escalating as these settings increasingly recognize its potential to significantly enhance patient care. By integrating individual genetic information, hospitals and clinics can offer more accurate diagnoses, effective treatments, and personalized care plans. This shift not only improves patient outcomes but also optimizes healthcare resources, reduces hospitalization rates, and tailors patient management, aligning with the evolving expectations of personalized healthcare.

Along with this, the growing need for precise, personalized diagnostic information to facilitate targeted treatment plans and improved patient outcomes is boosting the adoption of precision medicine approaches in diagnostic centers.

Moreover, pharma and biotech companies are increasingly investing in precision medicine to develop targeted therapies that offer higher efficacy and reduced risk, tailoring treatments to individual genetic profiles, which is further impelling the market growth.

In line with this, healthcare information technology (IT) firms play a pivotal role in advancing precision medicine, providing the data management and analytics capabilities essential for interpreting complex genomic data and supporting personalized healthcare solutions.

Other sectors, including research institutions and academic centers, are further boosting the demand for precision medicine by pioneering innovative approaches and technologies that enable personalized treatment strategies and advance the field of individualized care.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest precision medicine market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America's robust healthcare infrastructure, substantial investments in healthcare technology, and a strong emphasis on research and innovation are presenting lucrative opportunities for market expansion. The region's advanced regulatory framework supports the rapid adoption of personalized therapies, while the presence of leading biotech and pharmaceutical companies is fueling continuous advancements in precision medicine. Additionally, the presence of a well-informed population with increasing healthcare expectations is further providing an impetus to the market growth.

Besides this, the strong governmental support in Europe, extensive research collaborations, and well-established healthcare systems prioritizing personalized healthcare solutions and innovation in precision medicine are aiding in market expansion.

Concurrently, rapidly growing healthcare infrastructure, increasing investments in biotechnology, and rising awareness of personalized medicine's benefits are fueling the demand in the Asia Pacific region.

Furthermore, In Latin America, growing healthcare expenditure, increasing focus on research and development, and the rising prevalence of chronic diseases are boosting the adoption of precision medicine.

Apart from this, the demand in the Middle East and Africa is propelled by increasing healthcare investments, government initiatives to incorporate advanced healthcare technologies, and the rising demand for effective, personalized therapeutic approaches.

Leading Key Players in the Precision Medicine Industry:

The competitive landscape of the global precision medicine market is intensely dynamic and characterized by rapid technological advancements, strategic collaborations, and a strong focus on innovation. Major players in the field, including biotechnology firms, pharmaceutical giants, and healthcare IT companies, are continually expanding their product portfolios and enhancing their capabilities through research and development (R&D) investments, mergers and acquisitions, and partnerships with academic institutions and research organizations. These companies are competing fiercely to develop and commercialize precision medicine solutions that include advanced genomic analysis, biomarker detection, and personalized therapeutic interventions. The market is also witnessing a growing emphasis on regulatory compliance and the establishment of robust intellectual property rights, which are crucial for sustaining competitive advantage.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • AstraZeneca plc
  • Bayer AG
  • bioMerieux SA
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Illumina Inc.
  • Laboratory Corporation of America Holdings
  • Merck KGaA
  • Novartis AG
  • Pfizer Inc.
  • Qiagen N.V.
  • Quest Diagnostics Incorporated
  • Thermo Fisher Scientific Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Latest News:

  • In December 2023, AstraZeneca acquired CAR-T Firm Gracell to enhance its existing capabilities and previous investments in cell therapy in hematology and bring a potential best-in-class treatment to patients living with blood cancers.
  • In May 2023, Bayer launched a business unit focused on developing new Precision Health products across its range of everyday health categories.
  • In February 2023, Roche announced the expansion of its partnership with Janssen Biotech Inc. (Janssen), aiming to develop companion diagnostics for targeted treatments, thereby enhancing their joint research and innovation efforts.

Key Questions Answered in This Report:

  • How has the global precision medicine market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global precision medicine market?
  • What is the impact of each driver, restraint, and opportunity on the global precision medicine market?
  • What are the key regional markets?
  • Which countries represent the most attractive precision medicine market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the precision medicine market?
  • What is the breakup of the market based on technology?
  • Which is the most attractive technology in the precision medicine market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the precision medicine market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the orthodontic consumables market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global precision medicine market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Precision Medicine Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Consumables
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Big Data Analytics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Bioinformatics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Gene Sequencing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Drug Discovery
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Companion Diagnostics
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Oncology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Central Nervous System (CNS)
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Immunology
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Respiratory Medicine
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Infections
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Diagnostic Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Pharma and Biotech Companies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Healthcare IT Firms
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 AstraZeneca plc
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Bayer AG
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 bioMerieux SA
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Bristol-Myers Squibb Company
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Eli Lilly and Company
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 F. Hoffmann-La Roche AG
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 SWOT Analysis
    • 15.3.7 Illumina Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Laboratory Corporation of America Holdings
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Merck KGaA
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Novartis AG
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Pfizer Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Qiagen N.V.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13 Quest Diagnostics Incorporated
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis
    • 15.3.14 Thermo Fisher Scientific Inc.
      • 15.3.14.1 Company Overview
      • 15.3.14.2 Product Portfolio
      • 15.3.14.3 Financials
      • 15.3.14.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Precision Medicine Market: Major Drivers and Challenges
  • Figure 2: Global: Precision Medicine Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Precision Medicine Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Precision Medicine Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Precision Medicine Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: Precision Medicine Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Precision Medicine Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Precision Medicine Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Precision Medicine (Consumables) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Precision Medicine (Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Precision Medicine (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Precision Medicine (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Precision Medicine (Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Precision Medicine (Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Precision Medicine (Big Data Analytics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Precision Medicine (Big Data Analytics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Precision Medicine (Bioinformatics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Precision Medicine (Bioinformatics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Precision Medicine (Gene Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Precision Medicine (Gene Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Precision Medicine (Drug Discovery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Precision Medicine (Drug Discovery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Precision Medicine (Companion Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Precision Medicine (Companion Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Precision Medicine (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Precision Medicine (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Precision Medicine (Oncology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Precision Medicine (Oncology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Precision Medicine (Central Nervous System-CNS) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Precision Medicine (Central Nervous System-CNS) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Precision Medicine (Immunology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Precision Medicine (Immunology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Precision Medicine (Respiratory Medicine) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Precision Medicine (Respiratory Medicine) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Precision Medicine (Infections) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Precision Medicine (Infections) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Precision Medicine (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Precision Medicine (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Precision Medicine (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Precision Medicine (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Global: Precision Medicine (Diagnostic Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Global: Precision Medicine (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Global: Precision Medicine (Pharma and Biotech Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Global: Precision Medicine (Pharma and Biotech Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Global: Precision Medicine (Healthcare IT Firms) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Global: Precision Medicine (Healthcare IT Firms) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Global: Precision Medicine (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Global: Precision Medicine (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: North America: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: North America: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: United States: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: United States: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Canada: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Canada: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Asia-Pacific: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Asia-Pacific: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: China: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: China: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Japan: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Japan: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: India: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: India: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: South Korea: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: South Korea: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Australia: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Australia: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Indonesia: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Indonesia: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Others: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Others: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Europe: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Europe: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Germany: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Germany: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: France: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: France: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: United Kingdom: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: United Kingdom: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Italy: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Italy: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Spain: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Spain: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Russia: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Russia: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Others: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Others: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Latin America: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Latin America: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Brazil: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 90: Brazil: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 91: Mexico: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 92: Mexico: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 93: Others: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 94: Others: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 95: Middle East and Africa: Precision Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 96: Middle East and Africa: Precision Medicine Market: Breakup by Country (in %), 2023
  • Figure 97: Middle East and Africa: Precision Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 98: Global: Precision Medicine Industry: SWOT Analysis
  • Figure 99: Global: Precision Medicine Industry: Value Chain Analysis
  • Figure 100: Global: Precision Medicine Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Precision Medicine Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Precision Medicine Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Precision Medicine Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: Precision Medicine Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Precision Medicine Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Precision Medicine Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Precision Medicine Market: Competitive Structure
  • Table 8: Global: Precision Medicine Market: Key Players